Press release
RNAi for Therapeutic Market 2021 Precise Outlook - Alnylam Pharmaceuticals, Arbutus Biopharma (Tekmira), Arrowhead
The "RNAi for Therapeutic" Market report offers qualitative and quantitative insights and a detailed analysis of market size & growth rate for all possible segments in the market. The Global RNAi for Therapeutic Industry presents a market overview, product details, classification, and market concentration. The report also provides an in-depth survey of key players in the market which is based on various competitive intelligence parameters like company profiles, product picture and specification, capacity, production, price, cost, revenue, and contact information. The RNAi for Therapeutic Market report provides an in-depth study of SWOT analysis i.e. Strength, Weakness, Opportunities, and Threat to the organization.Click here to get a Free Sample Copy of the Report: (Flat 25%)
https://www.marketinsightsreports.com/reports/09033229106/global-and-china-rnai-for-therapeutic-market-size-status-and-forecast-2021-2027/inquiry?mode=70
Top Companies in the Global RNAi for Therapeutic Market: Alnylam Pharmaceuticals, Arbutus Biopharma (Tekmira), Arrowhead, Dicerna Pharmaceuticals, Mirna Therapeutics, Quark Pharmaceuticals, RXi Pharmaceuticals, Silence Therapeutics, Benitec Biopharma, miRagen Therapeutics, Sylentis, Gradalis, Sirnaomics, Silenseed
The global RNAi for Therapeutic market size is projected to reach US$ 1511.3 million by 2027, from US$ 131 million in 2020, at a CAGR of 43.1% during 2021-2027.
Industry News:
PASADENA, Calif. & DUBLIN-- Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) and Horizon Therapeutics plc (NASDAQ: HZNP) today announced a global collaboration and license agreement for ARO-XDH, a previously undisclosed discovery-stage investigational RNA interference (RNAi) therapeutic being developed by Arrowhead as a potential treatment for people with uncontrolled gout.
Market Overview:
RNAi is now known as precise, efficient, stable and better than antisense technology for gene suppression.
Global RNAi for Therapeutic key players include Alnylam Pharmaceuticals, Arbutus Biopharma (Tekmira), Arrowhead, Dicerna Pharmaceuticals, Mirna Therapeutics, etc. Global top five manufacturers hold a share over 85%.
US is the largest market, with a share over 75%, followed by EU, which has a share about 3%.
In terms of product, siRNA is the largest segment, with a share over 55%. And in terms of application, the largest application is Cancer, followed by HBV, Cardiovascular, etc.
This report segments the global RNAi for Therapeutic market on the basis of Types is:
siRNA
miRNA
shRNA
On the basis of Application, the Global RNAi for Therapeutic market is segmented into:
Cancer
Cardiovascular
HBV
Others
The research study evaluates the overall size of the market, by making use of a bottom-up approach, wherein data for different industry verticals, and end-user industries and its applications across various product types have been recorded and predicted during the forecast period. These segments and sub-segments have been documented from the industry specialists and professionals, as well as company representatives, and are outwardly validated by analysing previous year's data of these segments and sub-segments for getting an accurate and complete RNAi for Therapeutic market size.
Influence of the RNAi for Therapeutic Market Report:
-Comprehensive assessment of all opportunities and risk in the RNAi for Therapeutic market.
-RNAi for Therapeutic market recent innovations and major events.
-Detailed study of business strategies for growth of the RNAi for Therapeutic market-leading players.
-Conclusive study about the growth plot of RNAi for Therapeutic market for forthcoming years.
-In-depth understanding of RNAi for Therapeutic market-particular drivers, constraints and major micro markets.
-Favourable impression inside vital technological and market latest trends striking the RNAi for Therapeutic market.
For more information of this report:
https://www.marketinsightsreports.com/reports/09033229106/global-and-china-rnai-for-therapeutic-market-size-status-and-forecast-2021-2027?mode=70
The report provides insights on the following pointers:
Chapter 1 Study Coverage
Chapter 2 Executive Summary
Chapter 3 RNAi for Therapeutic Market Competitor Landscape by Players
Chapter 4 RNAi for Therapeutic Market Size by Type and Application
Chapter 5 Global and Regional Analysis
Chapter 6 Company Profiles, recent developments, and investments
Chapter 7 Market Opportunities, Challenges, Risks and Influences Factors Analysis
Chapter 8 Value Chain and Sales Channels Analysis with breakthrough product developments
Chapter 9 Research Findings and Conclusion
Chapter 10 Methodology/Research Approach
Finally, the RNAi for Therapeutic Market report is the believable source for gaining the market research that will exponentially accelerate your business. The report gives the principal locale, economic situations with the item value, benefit, limit, generation, supply, request and market development rate and figure, and so on. RNAi for Therapeutic industry report additionally Presents a new task SWOT examination, speculation attainability investigation, and venture return investigation.
Buy Full Report @:
https://www.marketinsightsreports.com/report/purchase/09033229106?mode=su?mode=70
We also offer customization on reports based on specific client requirement:
1- Free country level analysis for any 5 countries of your choice.
2- Free competitive analysis of any 5 key market players.
3- Free 40 analyst hours to cover any other data points
Please connect with our sales team (sales@marketinsightsreports.com).
Contact Us:
Irfan Tamboli (Head of Sales) – Market Insights Reports
Phone: + 1704 266 3234 | +91-750-707-8687
sales@marketinsightsreports.com | irfan@marketinsightsreports.com
About Us:
MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc.MarketInsightsReports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release RNAi for Therapeutic Market 2021 Precise Outlook - Alnylam Pharmaceuticals, Arbutus Biopharma (Tekmira), Arrowhead here
News-ID: 2509012 • Views: …
More Releases from Market Insights Reports
RTK Receiver Market Competition Strategies, Revenue Analysis, Key Players, Regio …
The qualitative report published by market intelligence data research on the RTK Receiver Market offers an in-depth examination of the current trends, latest expansions, conditions, market size, various drivers, limitations, and key players along with their profile details. The RTK Receiver market report offers the historical data for 2017 to 2022 and also makes available the forecast data from the year 2023 to 2029 which is based on revenue. With…
Head Emergency Immobilizer Market: Size, Share, Trends, Growth, and Revenue Proj …
****Revolutionary New Findings have been Uncovered in the Latest Research Report.….!
Global Head Emergency Immobilizer market Size, Status, and forecast for the 2023-2029 .The research provides accurate economic, global, and country-level predictions and analyses. It provides a comprehensive perspective of the competitive market as well as an in-depth supply chain analysis to assist businesses in identifying major changes in industry practices. The market report also examines the current state of the…
4D Diagnostic Ultrasound System Market to See Huge Growth & Profitable Business …
****Revolutionary New Findings have been Uncovered in the Latest Research Report.….!
Global 4D Diagnostic Ultrasound System market Size, Status, and forecast for the 2023-2029 .The research provides accurate economic, global, and country-level predictions and analyses. It provides a comprehensive perspective of the competitive market as well as an in-depth supply chain analysis to assist businesses in identifying major changes in industry practices. The market report also examines the current state of…
Caulk Market 2023 Report Provides Pin Point Analysis of Changing Competition Dyn …
The qualitative report published by market intelligence data research on the Caulk Market offers an in-depth examination of the current trends, latest expansions, conditions, market size, various drivers, limitations, and key players along with their profile details. The Caulk market report offers the historical data for 2017 to 2022 and also makes available the forecast data from the year 2023 to 2029 which is based on revenue. With the help…
More Releases for RNA
Global RNA Analysis/Transcriptomics Market Report
The Global RNA Analysis / Transcriptomics Market is projected to expand at a CAGR of 12.5% during the forecast period, to hit USD 8.1 Billion by 2026, according to a recent market report compiled by Global Market Estimates. Due to the rising need for personalized medicines, the demand for RNA Analysis / Transcriptomics is expected to raise the market demand.
Browse 156 Market Data Tables and 112 Figures spread through 175…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
Senior experts from Exicure, Roche, GSK, BioNTech RNA Pharmaceuticals & MiNA The …
With less than 4 weeks until SMi’s 10th annual RNA Therapeutics event (http://www.therapeutics-rna.com/openpr) opens its doors in London, UK next month, registration will soon be closing and delegate places are becoming increasingly limited.
Over the course of 2 focused days, attendees will be able to have an exclusive look into key developments in oligonucleotide therapeutics, mRNA technology, delivery mechanisms, and much more, led by industry leaders, scientific pioneers, and academics exploring…
RNA Therapy Improves Vision in Child Blindness, hear more about recent developme …
SMi Reports: In light of recent developments in the field of RNA Therapy, SMi’s 10th Annual RNA Therapeutics is set to deliver the latest advancements in February this year.
Leber congenital amaurosis (LCA), one of the most common causes of blindness in children, has been the subject of successful RNA therapy as researchers at the University of Pennsylvania recently published new data showing the success of the new therapy which improved…
New Confirmed Delegates & Speakers for RNA Therapeutics
SMi are thrilled to welcome Dr. James Hamilton, Vice President, Head of Clinical Development, Arrowhead Pharmaceuticals onto the speaker panel RNA Therapeutics 2018!
Dr. James Hamilton is currently responsible for all aspects of clinical trial design, implementation and execution. In this role, Dr. Hamilton managed the ARC-520 and ARC-AAT global programs through Phase 2 of development. Previously, Dr. Hamilton was Medical Director and Head of Corporate Development at Arrowhead. He led…
Introducing the 9th Annual RNA Therapeutics 2018
As the requirement for targeted solutions for chronic diseases continues to grow, the interest of pharmaceutical and biotech companies has increasingly focused towards RNA therapeutics, such that by 2020, the RNA Therapeutics Market is predicted to attain $1.2 billion.
One of the main challenges in RNA Therapeutics continues to be bridging the gap between in-vivo and in-vitro models, hear key case studies on the development on the latest delivery systems and…
